Model-Informed Assessment of Probability of Phase 3 Success for Ritlecitinib in Patients with Moderate-to-Severe Ulcerative Colitis
PMID: 38627914
Source: Clin Pharmacol Ther
Publication date:
2025-07-24
Year:
2024
Abstract
NULL